Intellectus Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,900
Closed -$226K 272
2022
Q3
$226K Hold
8,900
0.08% 217
2022
Q2
$296K Buy
8,900
+70
+0.8% +$2.97K 0.1% 200
2022
Q1
$637K Buy
8,830
+5
+0.1% +$360 0.19% 139
2021
Q4
$810K Sell
8,825
-2,410
-21% -$288K 0.21% 130
2021
Q3
$1.43M Buy
11,235
+285
+3% +$41.5K 0.34% 77
2021
Q2
$1.82M Buy
10,950
+1,645
+18% +$267K 0.41% 57
2021
Q1
$1.69M Buy
9,305
+4,555
+96% +$1.06M 0.46% 58
2020
Q4
$950K Buy
+4,750
New +$966K 0.28% 109

Other funds holding TDOC

Intellectus Partners's TDOC Position: Q4 2022 in Review

Intellectus Partners sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 8,900 shares — an estimated $226K sold.

Intellectus Partners first reported a position in TDOC in Q4 2020 and held it in 8 quarters. The position peaked at $1.82M in Q2 2021. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Intellectus Partners reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Intellectus Partners sold 8,900 Teladoc Health shares in Q4 2022, an estimated $226K.
  • Intellectus Partners first reported a position in Teladoc Health in Q4 2020 and held it in 8 quarters.
  • Intellectus Partners's Teladoc Health position peaked at $1.82M in Q2 2021.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Intellectus Partners's 13F filing for Q4 2022, filed 2 Feb 2023.